GET A VALUABLE CERTIFICATE FOR JOB MARKET


ACADEMIC RECOGNITION OF 3 OR 6 CREDITS


DESIGNED FOR EXPERTS BY EXPERTS


INTRODUCTION TO BENEFIT-RISK ASSESSMENT AND PHARMACOECONOMICS IN DECISION MAKING


OBJECTIVES



The objective of the module is to gain insight in the role of benefit-risk assessment and pharmacoeconomics in the process of decision-making on medicines by different stakeholders.

At the end of this module, you will be able to:

delineate the process of decision-making and the perspectives of the stakeholders involved

explain the rationale of benefit-risk assessment and pharmacoeconomic evaluation

evaluate the methodology and results of benefit-risk and pharmaco-economic studies

translate of the results into the process of decision-making

Benefit-risk assessment, decision making, pharmacoeconomics, communication

 

MODULE PARTS



  1. Introduction
  2. Benefits
  3. Risk/Harms
  4. Principles and methods of comparative benefit-risk assessment
  5. Principles of Pharmacoeconomics

 

TRAINER TEAM



Coordinator: Renske Ten Ham (from Utrecht Universiteit)

Expert(s): Prof Olaf Klungel, Prof Anthonius De Boer, Prof Hubert Leufkens, Dr Anke Hovels, Dr Rob Heerdink, Lotte Falke, Romin Pajouheshnia (from Utrecht Universiteit), Dr George Quartey (from F. Hoffmann-La Roche Ltd).

Introductory level
75 h workload over 3 months (3 ECTS credits)
Key dates
Course calendar
Certificate award
or included in Master Year 2 programme
English language
Online based learning
Student: 1,500 €
Professional: 3,000 €
  Savings could be offered under eligibility conditions.

APPLY NOW

Applications open until September 08th, 2019

Or include this module in your training curriculum choices...

Master Year 2 PhD



Confused? Read the FAQs...

NEED TO TALK TO US?

+33 5 47 30 42 69

Monday-Friday / 9.00am-6.00pm CET

 

Powered By

Eu2P Executive Board partners

Created By

Eu2P project consortium partners